4 completed, 1 not yet recruiting, 1 unknown. 6 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 4 | Completed 2, Not yet recruiting 1, Unknown 1 |
Follow Steroid: new trials by email Literature Review of Steroid trials Research Report on Steroid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antibiotics vs Corticosteroids in Treatment of Granulomatous Lobular Mastitis Steroid, Antibiotic - Granulomatous Mastitis | Phase 1 / Phase 2 | Not yet recruiting | All India Institute of Medical Sciences, Bhubaneswar | 72 | 2026-03-15 | 2026-03-06 |
| Follow-up and Steroid Treatment Results in Intussusception Methylprednisolone - Intussusception | Phase 1 / Phase 2 | Completed | Baskent University | 92 | 2019-12-24 | 2025-02-05 |
| Ruxolitinib Plus LVP in Patients With R/R ETP-ALL Ruxolitinib, Vincristine, Prednisone - Acute T Cell Leukemia | Phase 1 / Phase 2 | Unknown | Sichuan University | 12 | 2018-12-01 | 2018-08-03 |
| Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas LMP744, Ondansetron, Olanzapine - Solid Tumors, Lymphoma | Phase 1 | Completed | National Cancer Institute (NCI) | 36 | 2017-02-27 | 2024-12-10 |
| Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma ACY-1215, lenalidomide, Dexamethasone - Multiple Myeloma | Phase 1 | Completed | Celgene | 38 | 2012-07-12 | 2022-02-23 |
| Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis MRX-6, Steroid - Allergic Contact Dermatitis | Phase 1 / Phase 2 | Completed | Hadassah Medical Organization | 13 | 2011-03-01 | 2015-04-21 |
Dermatitis, Allergic Contact (1) · Dermatitis, Contact (1) · Eczema (1) · Granulomatous Mastitis (1) · Intussusception (1) · Lymphoma (1) · Multiple Myeloma (1) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1)
All India Institute of Medical Sciences, Bhubaneswar (1) · Baskent University (1) · Celgene (1) · Hadassah Medical Organization (1) · National Cancer Institute (NCI) (1) · Sichuan University (1)
United States (2) · India (1) · Israel (1) · Turkey (Türkiye) (1)
Alice P Chen, M.D. (1) · Jie Ji, MD (1) · Tushar Subhadarshan Mishra, MBBS,MS (1) · Yuval Ramot, MD (1)